This is in accordance with the clinical evidence that expression of PD‐L1 is significantly negatively correlated with infiltration of CD8+ T cells, such as in ovarian cancer and NSCLC [246, 247]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.